Low serum folate concentrations are associated with an excess incidence of acute coronary events: The Kuopio Ischaemic Heart Disease Risk Factor Study

European Journal of Clinical Nutrition

Volumn 54, Issue 5, 2000, Pages 424-428

  Voutilainen, S ^a   Lakka, T A ^a   Porkkala Sarataho, E ^a   Rissanen, T ^a   Kaplan, G A ^b   Salonen, J T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute coronary event; Cohort studies; Finland; Folate; Homocysteine; Myocardial infarction; Prospective studies

Indexed keywords

FOLIC ACID; LYCOPENE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FINLAND; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RADIOIMMUNOASSAY;

ADULT; CARDIOVASCULAR DISEASES; CAROTENOIDS; COHORT STUDIES; CORONARY DISEASE; FINLAND; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034063582     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600991     Document Type: Article

References (28)

1. Alfthan G, Pekkanen J, Jauhiainen M, Pitkániemi J, Karvanen M, Tuomilehto J, Salonen JT, Enholm C (1994): Relation of serum homocysteine and lipoprotein(a)concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106, 9-19.
2. Alfthan G, Aro A & Gey F (1997). Serum homocysteine and cardiovascular disease mortality. Lancet 349, 97.
3. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, & Nordehaug JE (1998): Serum total homocysteine concentration and coronary heart disease. Int. J. Epidemiol. 24, 704-709.
4. Boushey CJ, Baresford SAA, Omenn GS & Molutsky AG (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274, 1049-1057.
5. Brattström L, Wilcken D, Öhrvik J, & Brudin L (1998): Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular diasease. The result of a metaanalysis. Circulation 98, 2520-2526.
6. 6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr. 15, 136-143.
7. Evans RW, Shaten BJ, Hempel JD, Cutler JA & Kuller LH, for the MRFIT Research Group (1997): Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler. Thromb. Vasc. Biol. 17, 1947-1953.
8. Folsom AR, Nieto FJ, McGovern PG, Tsai NY, Malinow MR, Eckleldt JH, Hess DL, Davis FJ (1998): Prospective study of coronary heart disease incidence in relation to total homocysteine, related genetic polymorphism, and B vitamins. Circulation 98, 204-210.
9. Giles WH, Kittner SJ, Anda RF, Croft JB & Michele CL (1995): Serum folate and risk for ischemic stroke: First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Stroke 26, 1166-1170.
10. Giles WH, Kittner SJ, Croft JB, Anda RF, Casper ML & Ford ES. (1998): Serum folate and risk for coronary heart disease: Results from cohort of US adults. Ann. Epidemiol. 8, 490-496.
11. Homocysteine Lowering Trialists' Collaboration (1998): Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br. Med. J. 316, 894-898.
12. Jacobsen DW (1998): Homocysteine and vitamins in cardiovascular disease. Clin. Chem. 44, 1833-1843.
13. Morrison HI, Schaubel D, Desmeules M & Wigle DT (1996): Serum folate and risk of fatal coronary heart disease. JAMA 275, 1893-1896.
14. National Public Health Institute: Nutrition Report (1998): National Public Health Institute, Helsinki, Finland.
15. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM & Shaper AG (1995): Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, 1395-1398.
16. Porkkala-Sarataho E, Nyyssönen K, Kaikkonen J, Poulsen HE, Haun EM, Salonen RM, Salonen JT (1998): A randomized, single-blinded, placebo-controlled trial of the effects of zooma alpha-tocopherol in oxidation resistance of atherogenic lipoproteins and vitamin E absorption. Am. J. Clin. Nutr. 68, 1034-1041.
17. Refsum H, Ueland PM, Nygård O & Vollset SE (1998): Homocysteine and cardiovascular disease. A. Rev. Med. 49, 31-62.
18. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279, 359-364.
19. Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Heland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witterman J, Graham J (1998): For the European COMAC group. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97, 437-443.
20. Salonen JT (1988): Is there a continuing need for longitudinal epidemiologic research? The Kuopio lschaemic Heart Disease Risk Factor Study. Ann. Clin. Res. 20, 46-50.
21. Salonen JT, Nyyssönen K, Tuomainen T-P, Maenpaa PH, Korpeal H, Kaplan GA, Lynch J, Helmrich SP, Salonen R (1998): Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentration: a four year follow-up study in men. Br. Med. J. 311, 1124-1127.
22. Selhub J, Jacques PF, Wilson PWF, Rush D & Rosenberg IH (1993): Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693-2698.
23. Stampfer MJ, Malinow R, Willett WC, Newcomer LM, Upson B, Ullmann D, Tiswer PV, Hennckens CH (1992): A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-881.
24. Tuomilehto J, Arstila M, Kaarsalo E Kankaanpaa J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, et al (1992): Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983-1985. Eur. Heart J. 13, 577-587.
25. Ubbrink JB, Vermaak WJH, van der Merve A, Becker PJ, Delport R & Potgieter HC (1994): Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124, 1927-1933.
26. Verhoef P, Hennekens Ch, Malinow R, Kok FJ, Willett WC & Stampfer MJ (1994): A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25, 1924-1930.
27. Verhoef P, Stampfer MJ & Rimm EB (1998) Folate and coronary heart disease. Curr. Opin. Lipid 9, 17-22.
28. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J & Scott JM (1998): Homocysteine and ischeamic heart disease: result of a prospective study with implications regarding prevention. Arch. Intern. Med. 158, 862-867.